Abstract:3D bioprinting technology is advancing rapidly to construct multi-scale preformed architectures that satisfy the demands of tissue regeneration. However, challenges remain in accurately delivering large-sized preformed architectures to the defect sites without being damaged by the mechanical environment in vivo. In this study, we proposed a versatile bioprinting strategy to fabricate large-sized architectures with remarkable injection capacity for geometry-independent minimally invasive tissue delivery. We design a novel hydrogel by mixing gelatin methacryloyl with poly(ethylene glycol) diacrylate (PEGDA) and photocrosslinking the mixture under a white light source. The hydrogel forms a reinforced crosslinking network, exhibiting superelasticity and fatigue resistance. We infer that the flexible chains of high-molecular-weight PEGDA and interconnected macropores of hydrogel contribute to the reinforcement mechanisms. With a decoupled bioprinting strategy, the bioink can be 3D printed into large-sized architectures with different geometries and tunable Poisson’s ratio. The printing architectures displayed excellent deformation and shape recovery capacity by compressing to less than 1% of the original size and fully recovering after injection. The injection capacity is geometry-independent, indicating the intrinsic properties of the hydrogel and allowing higher freedom for the structural design and geometry size of the architectures. The bioprinting process is compatible with genome-edited hepatic cells with high cell-bioprinting suitability, demonstrating high cell viability, a minimally altered transcriptomic profile after bioprinting, and a biocompatible microenvironment that supports cell survival and hepatic function maintenance. The cell-laden architectures express uncompromised injection capacity with unaffected cell viability after injection. This study presents a generalizable strategy for preparing and bioprinting with superelastic and fatigue-resistant bioinks into customized cell-laden architectures to facilitate minimally invasive large-sized tissue delivery.

Clinically Relevant and Precisely Printable Live Adipose Tissue–Based Bio‐Ink for Volumetric Soft Tissue Reconstruction

Rapid Printing of 3D Porous Scaffolds for Breast Reconstruction

Preclinical Optimization of a Shelf-Ready, Injectable, Human-Derived, Decellularized Allograft Adipose Matrix.

Thermo-sensitive Sacrificial Microsphere-based Bioink for Centimeter-scale Tissue with Angiogenesis

Engineering 3D-Printed Bioresorbable Scaffold to Improve Non-Vascularized Fat Grafting: A Proof-of-Concept Study

An immunologically active, adipose-derived extracellular matrix biomaterial for soft tissue reconstruction: concept to clinical trial

3D Bioprinting of Thick Adipose Tissues with Integrated Vascular Hierarchies

Directly Coaxial 3D Bioprinting of Large-Scale Vascularized Tissue Constructs.

Sacrificial Microgel-Laden Bioink-Enabled 3D Bioprinting of Mesoscale Pore Networks

Towards optimized tissue regeneration: a new 3D printable bioink of alginate/cellulose hydrogel loaded with thrombocyte concentrate

Three-dimensional Bioprinting of a Full-Thickness Functional Skin Model Using Acellular Dermal Matrix and Gelatin Methacrylamide Bioink

Freeform laser and inkjet printing of biological constructs

Rapid printing of bio-inspired 3D tissue constructs for skin regeneration

3D Printing of Vascularized Hepatic Tissues with a High Cell Density and Heterogeneous Microenvironment.

An Approach for Fabricating Hierarchically Porous Cell‐Laden Constructs Utilizing a Highly Porous Collagen‐Bioink

Microfiber-Templated Porogel Bioinks Enable Tubular Interfaces and Microvascularization Down to the Building Blocks for 3D Bioprinting

Digital light processing-based bioprinting of microtissue hydrogel arrays using dextran-induced aqueous emulsion ink

Bioprinting with Superelastic and Fatigue-Resistant Bioinks for Large-Sized Tissue Delivery

Extracellular‐Matrix‐Reinforced Bioinks for 3D Bioprinting Human Tissue

Advances in Cell‐Rich Inks for Biofabricating Living Architectures

Non-animal derived recombinant collagen-based biomaterials as a promising strategy towards adipose tissue engineering